Soluble NKG2D ligands impair CD8 + T cell antitumor function dependent of NKG2D downregulation in neuroblastoma
Oncology Letters · 24.05.2023 · 26 (1)
DOI: 10.3892/ol.2023.13883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 24.05.2023. Verfasst von Yi Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai 201102, P.R. China. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai 201102, P.R. China.
- Biotherapy Research Center, Fudan University, Shanghai 200040, P.R. China.
- Department of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Zitieren
APA
Zhang, Y., Luo, F., & Dong, K. (2023). Soluble NKG2D ligands impair CD8 + T cell antitumor function dependent of NKG2D downregulation in neuroblastoma. Oncology Letters, 26(1). https://doi.org/10.3892/ol.2023.13883
Vancouver
Zhang Y, Luo F, Dong K. Soluble NKG2D ligands impair CD8 + T cell antitumor function dependent of NKG2D downregulation in neuroblastoma. Oncology Letters. 2023;26(1). doi:10.3892/ol.2023.13883
BibTeX
@article{Zhang2023,
author = {Zhang, Yi and Luo, Feifei and Dong, Kuiran},
title = {Soluble NKG2D ligands impair CD8 + T cell antitumor function dependent of NKG2D downregulation in neuroblastoma},
journal = {Oncology Letters},
year = {2023},
volume = {26},
number = {1},
doi = {10.3892/ol.2023.13883}
}
EUVIMED